Have you been diagnosed with congenital adrenal hyperplasia (CAH)? You may be able to participate in a study to assess if a study drug called crinecerfont is effective in lowering the daily glucocorticoid dose that CAH patients need to control symptoms. Participation will last about 20 months and includes 21 study visits. Compensation is provided. Travel reimbursement may also be provided.